<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01078025</url>
  </required_header>
  <id_info>
    <org_study_id>EKSG09/150/1B</org_study_id>
    <nct_id>NCT01078025</nct_id>
  </id_info>
  <brief_title>Evaluation of Microbial Colonisation and Contamination Caused by the Transvaginal and Transabdominal Access for Cholecystectomy</brief_title>
  <acronym>NOBACT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transvaginal hybrid procedures are of interest as an available NOTES procedure for the
      clinical routine. The gynaecologists` experiences and the available studies report on low
      morbidity related to the transvaginal access. However, little is known about the vaginal and
      intraabdominal microbial contamination due to the transvaginal approach.

      The aim of this cohort study is to evaluate the microbial colonisation and contamination in
      patients with transvaginal hybrid and conventional laparoscopic cholecystectomy.

      Therefore, pre- and intraoperative microbiological evaluations will be performed in patients
      with transvaginal hybrid cholecystectomy and laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microbial colonisation and contamination vaginally and intraabdominally</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity (wound, vaginal and intraabdominal infection) two weeks and six weeks postoperatively</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>transvaginal hybrid cholecystectomy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic cholecystectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Smear test vaginally, intraabdominally</intervention_name>
    <description>Pre- and intraoperative smear tests of the vagina and douglas are performed.</description>
    <arm_group_label>transvaginal hybrid cholecystectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Smear test vaginally, intraabdominally</intervention_name>
    <description>Pre- and intraoperative smear tests of the vagina and douglas are performed.</description>
    <arm_group_label>laparoscopic cholecystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients with symptomatic cholecystolithiasis and given informed consent for
        laparoscopic cholecystectomy or transvaginal hybrid cholecystectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication for elective cholecystectomy

          -  informed consent for laparoscopic cholecystectomy or transvaginal hybrid
             cholecystectomy

        Exclusion Criteria:

          -  cholecystitis

          -  intraabdominal infection

          -  existing antibiotic therapy

          -  adnexitis

          -  pelvic inflammatory disease

          -  infection (CRP &gt; 10 mg /l; Lc &gt; 11 G/l)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Zerz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital St.Gallen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery</name>
      <address>
        <city>St.Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2010</study_first_posted>
  <last_update_submitted>December 9, 2010</last_update_submitted>
  <last_update_submitted_qc>December 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Andreas Zerz, MD</name_title>
    <organization>Cantonal Hospital St.Gallen, Departement of Surgery</organization>
  </responsible_party>
  <keyword>transvaginal access for cholecystectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

